Tu D - Search Results

1

M2 macrophages contribute to cell proliferation and migration of breast cancer.

Tu D, Dou J, Wang M, Zhuang H, Zhang X. Tu D, et al. Cell Biol Int. 2021 Apr;45(4):831-838. doi: 10.1002/cbin.11528. Epub 2021 Jan 13. Cell Biol Int. 2021. PMID: 33325089

2

MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.

Liu MM, Li Z, Han XD, Shi JH, Tu DY, Song W, Zhang J, Qiu XL, Ren Y, Zhen LL. Liu MM, et al. Sci Rep. 2017 Nov 21;7(1):15929. doi: 10.1038/s41598-017-16175-x. Sci Rep. 2017. PMID: 29162879 Free PMC article.

3

LncRNA PCAT18/miR-301a/TP53INP1 axis is involved in gastric cancer cell viability, migration and invasion.

Dou J, Tu D, Zhao H, Zhang X. Dou J, et al. Among authors: tu d. J Biochem. 2020 Nov 1;168(5):547-555. doi: 10.1093/jb/mvaa079. J Biochem. 2020. PMID: 32687182

4

Inhibition of miRNA-34a promotes triple negative cancer cell proliferation by promoting glucose uptake.

Li Z, Gong X, Zhang W, Zhang J, Ding L, Li H, Tu D, Tang J. Li Z, et al. Among authors: tu d. Exp Ther Med. 2019 Nov;18(5):3936-3942. doi: 10.3892/etm.2019.8017. Epub 2019 Sep 18. Exp Ther Med. 2019. PMID: 31616515 Free PMC article.

5

Degradation of PARP1 by MARCHF3 in tumor cells triggers cCAS-STING activation in dendritic cells to regulate antitumor immunity in hepatocellular carcinoma.

Cao J, Su B, Zhang C, Peng R, Tu D, Deng Q, Jiang G, Jin S, Wang Q, Bai DS. Cao J, et al. Among authors: tu d. J Immunother Cancer. 2024 Nov 27;12(11):e010157. doi: 10.1136/jitc-2024-010157. J Immunother Cancer. 2024. PMID: 39608977 Free PMC article.

6

A Functional Food Inhibits Azoxymethane/Dextran Sulfate Sodium-Induced Inflammatory Colorectal Cancer in Mice.

Zhang J, Chen Z, Lu Y, Tu D, Zou F, Lin S, Yu W, Miao M, Shi H. Zhang J, et al. Among authors: tu d. Onco Targets Ther. 2021 Feb 26;14:1465-1477. doi: 10.2147/OTT.S283465. eCollection 2021. Onco Targets Ther. 2021. PMID: 33664579 Free PMC article.

7

RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma.

Zhou J, Tu D, Peng R, Tang Y, Deng Q, Su B, Wang S, Tang H, Jin S, Jiang G, Wang Q, Jin X, Zhang C, Cao J, Bai D. Zhou J, et al. Among authors: tu d. Cell Commun Signal. 2023 Aug 25;21(1):224. doi: 10.1186/s12964-023-01241-x. Cell Commun Signal. 2023. PMID: 37626338 Free PMC article.

8

In vivo CRISPR screen identifies LTN1 as a novel tumor suppressor ubiquitinating insulin-like growth factor 2 mRNA-binding protein 1 in hepatocellular carcinoma.

Peng R, Cao J, Zhang C, Zhou J, Su BB, Tu DY, Jiang GQ, Jin SJ, Xu YP, Bai DS. Peng R, et al. Hepatol Commun. 2023 Sep 15;7(10):e0256. doi: 10.1097/HC9.0000000000000256. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37708447 Free PMC article.

9

Identifying epithelial-mesenchymal transition-related genes as prognostic biomarkers and therapeutic targets of hepatocellular carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data.

Chen C, Wang S, Tang Y, Liu H, Tu D, Su B, Peng R, Jin S, Jiang G, Cao J, Zhang C, Bai D. Chen C, et al. Among authors: tu d. Transl Cancer Res. 2024 Aug 31;13(8):4257-4277. doi: 10.21037/tcr-24-521. Epub 2024 Aug 22. Transl Cancer Res. 2024. PMID: 39262476 Free PMC article.

10

Identification of potential biomarkers for hepatocellular carcinoma based on machine learning and bioinformatics analysis.

Chen C, Peng R, Jin S, Tang Y, Liu H, Tu D, Su B, Wang S, Jiang G, Cao J, Zhang C, Bai D. Chen C, et al. Among authors: tu d. Discov Oncol. 2024 Dec 18;15(1):808. doi: 10.1007/s12672-024-01667-w. Discov Oncol. 2024. PMID: 39692931 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

911 results

Search Page

Filters